AU Stock MarketDetailed Quotes
DXB Dimerix Ltd
- 0.350
- +0.015+4.48%
20min DelayNot Open Nov 28 16:00 AET
195.24MMarket Cap-9210P/E (Static)
0.357High0.335Low1.30MVolume0.335Open0.335Pre Close453.82KTurnover0.66552wk High0.30%Turnover Ratio557.83MShares0.13552wk Low-0.038EPS TTM153.01MFloat Cap146582.030Historical HighLossP/E (Static)437.17MShs Float0.052Historical Low-0.038EPS LYR6.57%Amplitude--Dividend TTM10.61P/B1Lot Size--Div YieldTTM
About Dimerix Ltd Company
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Company Profile
SymbolDXB
Company NameDimerix Ltd
Founded1975
MarketASX
Employees12
Fiscal Year Ends06-30
Address425 Smith Street
CityFitzroy
CountryAustralia
Zip Code3065
Phone+61 1300813321
Websitehttps://www.dimerix.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Nina Webster
- Chief Executive Officer,Managing Director
- --
- Sonia Maria Poli
- Non-Executive Director
- --
- Mark P Diamond
- Non-Executive Director
- --
- Hugh Alsop
- Non-Executive Director
- --
- Clinton Snow
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data